Drug Knowledge Discovery Based on Meta-Path Features of Heterogeneous Knowledge Network: Case Study of Drug-Target Relationship Prediction

被引:0
作者
Zhu, Xiang [1 ]
Zhang, Yunqiu [2 ]
Sun, Shaodan [1 ]
Zhang, Liman [1 ]
机构
[1] School of Cyber Science and Engineering, Nanjing University of Science & Technology, Nanjing
[2] School of Public Health, Jilin University, Changchun
关键词
Drug Knowledge Discovery; Heterogeneous Knowledge Network; Machine Learning Drug-Target; Meta-Path;
D O I
10.11925/infotech.2096-3467.2023.0869
中图分类号
学科分类号
摘要
[Objective] This paper proposes a drug knowledge discovery method that fuses meta-path features of heterogeneous knowledge network to improve the performance of drug knowledge discovery. [Methods] Based on different meta-paths connecting drug and target entity in heterogeneous knowledge network, the HeteSim algorithm is used to calculate the multi-dimensional semantic similarity of drug-target entity. These meta-path features are fused with drug similarity and target entity similarity features as feature inputs for machine learning models to achieve drug knowledge discovery. [Results] The drug heterogeneous knowledge network contains 12, 015 nodes and 1, 895, 445 edges. Taking drug-target relation prediction as an example, the 21-dimensional HeteSim features between drug and target were calculated. The AUC value of this method achieved the highest value on the three machine learning models (XGBoost=0.993, RF=0.990, SVM=0.975). The accuracy, precision and F-value of this method are also higher than those of the other two comparison methods. Through literature search of 20 prediction results, it is found that some prediction results can be supported by evidence in previous literature. [Limitations] Although PU learning strategy is used to reduce the influence of sample imbalance, some results will still be distorted. [Conclusions] The drug knowledge discovery method proposed in this study has certain progressiveness and effectiveness, and has certain theoretical and methodological reference significance. © 2024 Chinese Academy of Sciences. All rights reserved.
引用
收藏
页码:125 / 135
页数:10
相关论文
共 50 条
[1]  
Pasrija P, Jha P, Upadhyaya P, Et al., Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery, Current Topics in Medicinal Chemistry, 22, 20, pp. 1692-1727, (2022)
[2]  
Gachloo M, Wang Y X, Xia J B., A Review of Drug Knowledge Discovery Using BioNLP and Tensor or Matrix Decomposition, Genomics & Informatics, 17, 2, (2019)
[3]  
Guo Yong, Luo Min, Xing Rui, Drug ADMET Intelligence Prediction Method for Knowledge Discovery, Information Science, 41, 2, pp. 95-100, (2023)
[4]  
Wang C, Kurgan L., Survey of Similarity-Based Prediction of Drug-Protein Interactions, Current Medicinal Chemistry, 27, 35, pp. 5856-5886, (2020)
[5]  
Kim Y, Jung Y S, Park J H, Et al., Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning, Biomolecules, 12, 10, (2022)
[6]  
Zhang C L, Zhang Y Z, Wang B, Et al., Prediction of Drug-Target Binding Affinity by an Ensemble Learning System with Network Fusion Information, Current Bioinformatics, 16, 10, pp. 1223-1235, (2021)
[7]  
Zhu Y, Che C, Jin B, Et al., Knowledge-Driven Drug Repurposing Using a Comprehensive Drug Knowledge Graph, Health Informatics Journal, 26, 4, pp. 2737-2750, (2020)
[8]  
Li Dongqiao, Chen Fang, Han Tao, Et al., Research on the Tacit Knowledge Discovery Based on Two-Mode Complex Network-Take Mining Potential Drug Targets as an Example, Library and Information Service, 64, 21, pp. 120-129, (2020)
[9]  
Lu Quan, Liu Ting, Zhang Liangtao, Et al., Study on Knowledge Discovery Model Based on Fuzzy Ontology Fusion and Reasoning, Journal of the China Society for Scientific and Technical Information, 40, 4, pp. 333-344, (2021)
[10]  
Zhang Han, An Xinyu, Liu Chunhe, Building Multi-Source Semantic Knowledge Graph for Drug Repositioning, Data Analysis and Knowledge Discovery, 6, 7, pp. 87-98, (2022)